105
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway

, , , , , , & show all
Pages 5057-5067 | Published online: 08 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yifan Zhou, Ammad Ahmad Farooqi & Baojun Xu. (2023) Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression. Critical Reviews in Food Science and Nutrition 63:20, pages 4325-4350.
Read now
S. N. Sankhwar, Pawan Kumar, Manashi Bagchi, Mehul Rungta & Debasis Bagchi. (2023) Safety and Efficacy of Furosap®, a Patented Trigonella foenum-graecum Seed Extract, in Boosting Testosterone Level, Reproductive Health and Mood Alleviation in Male Volunteers. Journal of the American Nutrition Association 42:1, pages 27-35.
Read now

Articles from other publishers (16)

Mehrdad Hashemi, Naghmeh Nazdari, Ghazaleh Gholamiyan, Mahshid Deldar Abad Paskeh, Ali Moghadas Jafari, Fateme Nemati, Elaheh Khodaei, Ghazal Abyari, Nazanin behdadfar, Behnaz Raei, Rasoul Raesi, Noushin Nabavi, Peng Hu, Mohsen Rashidi, Afshin Taheriazam & Maliheh Entezari. (2024) EZH2 as a potential therapeutic target for gastrointestinal cancers. Pathology - Research and Practice 253, pages 154988.
Crossref
Matheus Felipe da Silva, Luan Vitor Alves de Lima, Liana Martins de Oliveira, Simone Cristine Semprebon, Nayane de Oliveira Silva, Amanda Passuello de Aguiar & Mário Sérgio Mantovani. (2023) Regulation of cytokinesis and necroptosis pathways by diosgenin inhibits the proliferation of NCI-H460 lung cancer cells. Life Sciences 330, pages 122033.
Crossref
Yu-Fei Wang & Jin-Yue Hu. (2023) Natural and synthetic compounds for glioma treatment based on ROS-mediated strategy. European Journal of Pharmacology 953, pages 175537.
Crossref
Qun-li Ren, Qian Wang, Xin-qun Zhang, Miao Wang, Huan Hu, Jun-jie Tang, Xiong-tong Yang, Ying-hui Ran, Huan-huan Liu, Zhi-xing Song, Jian-guo Liu & Xiao-lan Li. (2023) Anticancer Activity of Diosgenin and Its Molecular Mechanism. Chinese Journal of Integrative Medicine 29:8, pages 738-749.
Crossref
Dan Chen, Chuqing Wu, Simin Wei, Yican Guo, Meng Wu, Su Zhou, Fangfang Fu, Weicheng Tang, Liru Xue, Jinjin Zhang, Yan Li, Jun Dai, Yuanyuan Li, Shuangmei Ye & Shixuan Wang. (2023) Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement. Molecular Human Reproduction 29:5.
Crossref
Antony Joseph Velanganni Arockiam, Nithya Ganesan & Devan Umapathy. (2023) DIOSGENIN AT THE CELLULAR LEVEL AS A CANCER REMEDIAL AGENT. Indian Drugs 60:04, pages 7-16.
Crossref
Adrian Kwan Ho Loe, Lexin Zhu & Tae-Hee Kim. (2023) Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis. Experimental & Molecular Medicine 55:1, pages 22-31.
Crossref
Lixia Dong, Jingqiu He, Li Luo & Kui Wang. (2023) Targeting the Interplay of Autophagy and ROS for Cancer Therapy: An Updated Overview on Phytochemicals. Pharmaceuticals 16:1, pages 92.
Crossref
Leonie Ratz, Chiara Brambillasca, Leandra Bartke, Maxim A. Huetzen, Jonas Goergens, Orsolya Leidecker, Ron D. Jachimowicz, Marieke van de Ven, Natalie Proost, Bjørn Siteur, Renske de Korte-Grimmerink, Peter Bouwman, Emilia M. Pulver, Roebi de Bruijn, Jörg Isensee, Tim Hucho, Gaurav Pandey, Maarten van Lohuizen, Peter Mallmann, Hans Christian Reinhardt, Jos Jonkers & Julian Puppe. (2022) Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Breast Cancer Research 24:1.
Crossref
Danial Hashemi KaroiiHossein Azizi & Mahdi Amirian. (2022) Signaling Pathways and Protein–Protein Interaction of Vimentin in Invasive and Migration Cells: A Review. Cellular Reprogramming 24:4, pages 165-174.
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, Farid Hashemi, Amirhossein Zabolian, Israel Canadas, Ali Zarrabi, Noushin Nabavi, Amir Reza Aref, Francesco Crea, Yuzhuo Wang, Milad Ashrafizadeh & Alan Prem Kumar. (2022) The long and short non-coding RNAs modulating EZH2 signaling in cancer. Journal of Hematology & Oncology 15:1.
Crossref
Si-Yuan Tang, Pei-Jun Zhou, Yu Meng, Fu-Rong Zeng & Guang-Tong Deng. (2022) Gastric cancer: An epigenetic view. World Journal of Gastrointestinal Oncology 14:1, pages 90-109.
Crossref
Nannan HUANG, Dan YU, Junkai WU & Xiaowei DU. (2022) Diosgenin: an important natural pharmaceutical active ingredient. Food Science and Technology 42.
Crossref
Seohyun Kim, Seong A. Kim, Jihoon Han & In-San Kim. (2021) Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential. International Journal of Molecular Sciences 22:23, pages 12916.
Crossref
Linshen Xie & Ye Zeng. (2020) Therapeutic Potential of Exosomes in Pulmonary Fibrosis. Frontiers in Pharmacology 11.
Crossref
Rakesh Kumar Sahu, Sakshi Singh & Raghuvir Singh Tomar. (2020) The mechanisms of action of chromatin remodelers and implications in development and disease. Biochemical Pharmacology 180, pages 114200.
Crossref